BioSpace News Archive

Bioclinica’s IRT reduces the average setup time 50 to 75 percent for each new study compared to IRT systems built from the ground up

iotaMotion Inc., an early-stage medical technology startup spun out of the University of Iowa’s Otolaryngology Department, announced today that the company has been awarded a $1.65M grant from the National Institutes of Health (NIH).

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that an independent analyst report by Ari Zoldan was published on Seeking Alpha, a crowd-sourced content service for financial markets.

Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the Cantor Virtual Global Healthcare Conference.

Incyte (Nasdaq:INCY) today announced that Massachusetts General Cancer Center is the recipient of the first Incyte Ingenuity Award, an annual program that was created to support people living with graft-versus-host disease (GVHD) by encouraging innovative and novel solutions that address specific challenges facing the GVHD community.

Inova Health System (“Inova”), a non-profit health organization, recently learned that Blackbaud, a third-party service vendor used for fundraising and alumni or donor engagement efforts at non-profits and universities worldwide, was the subject of a data security incident.

M400s being used to stream patient surgeries for up to 16 hours for education and training purposes

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a new collaboration with the Centers for Disease Control and Prevention (CDC) and the CDC Foundation that aims to expand lipid testing in resource-limited countries.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.